LBA79 GEMSTONE-303: Prespecified progression-free survival (PFS) and overall survival (OS) final analyses of a phase III study of sugemalimab plus chemotherapy vs placebo plus chemotherapy in treatment-naïve advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma
Xiao Zhang, J. Wang, Guoping Wang, Y. Zhang, Qingxia Fan, Liao Chuang-xin, Chengping Hu, Meili Sun, Yun Wan, Sanyuan Sun, Jun Wang, Li Zhang, Yongqian Shu, Jiefeng Luo, Dalong Zhu, Haiying Wang, Yi Xu, Qiang Shi, J. Joshua Yang, Lin Shen
Topics & Concepts
MedicineChemotherapyInternal medicineOncologyPlaceboProgression-free survivalPhases of clinical researchOverall survivalPathologyAlternative medicineGastric Cancer Management and OutcomesEsophageal Cancer Research and TreatmentColorectal Cancer Treatments and Studies